in , , , , , ,

Forbes China: 50 Women In Tech

Forbes China launched its first annual list to honor 50 Top Women in Tech in mainland China in 2019. The third edition is out in the latest issue of Forbes China magazine.

The list identified women that are making a mark in areas related to science, technology, engineering and math in business, government and education. All of the listees of the Forbes China 50 Top Women in Tech hold at least one degree in a STEM-related major. To give room to newcomers, we excluded members from last year’s list.

Our search for candidates included interviews with venture capitalists, female business leaders, and female leadership groups. We scanned other Forbes lists for candidates and leads, as well as the ranks of top China-related companies in technology and healthcare-related industries. In making the final cut, we took into account business size, job responsibilities, innovation and influence. Here is the full list in Chinese and below in English:

—Cao Ya, Independent Director, Sansure Biotech

—Chen Wei, Academician, Chinese Academy of Engineering; Researcher, Chinese Academy of Military Medicine

—Chen Wei, Principal Research Manager, Microsoft Research Asia; Doctoral Advisor, University of Science and Technology of China

—Chu Min, Vice President & General Manager of Intelligent Services Division, AiSpeech

—Selena (Xiaoqin) Chu, Vice President, Greater China, Dow Chemical

—Allison (Yuhong) Cui, Vice President & General Manager, Milliken Floor Covering Business, Asia, Milliken & Co.

—Cui Li, Chief Development Officer, ZTE

—Fan Bei, Executive Deputy General Manager, Hualan Biological Engineering

—Fu Ling, Vice President, Zoomlion Heavy Industry Science and Technology

—Fu Shaolan, Chairperson, Pacific Shuanglin Bio-pharmacy

—Gu Qun, Independent Director, Chaozhou Three-Circle (Group)

—Hong Jing, Founding Partner, Gaocheng Capital (See related post here)

—Huang Shalin, Deputy General Manager, Wangsu Science and Technology

—Jin Meilin, Vice Chairperson, Wuhan Keqian Biology

—Li Jia, Deputy General Manager, Haohua Chemical Science and Technology

—Li Ke, Vice President, BYD

—Li Xueying, Chairperson, Topsec Technologies Group

—Li Yuqian, Director of Developer Relations, Nvidia

—Liang Mengmeng, Co-founder & COO, Cipher Gene

—Ling Chen, Non-independent Director, Jiangsu Sopo Chemical

—Liu Ai’hua, Deputy General Manager, Bloomage Biotechnology

—Liu Sumin, Director, Tangshan Jidong Cement

—Liu Wenjing, Chairperson, Blue Sail Medical

—Lv Lilang, General Manager, Shanghai ZJ Bio-Tech

—Mo Luyi, Vice President & Head of Guangzhou R&D Center, Pony AI

—Shen Huaqiong, Chief Executive Officer, I-Mab Biopharma

—Shi Hena, Vice President, Betta Pharmaceuticals

—Sophie (Zhengjie) Sun, Senior Vice President of Corporate Development, Apollomics

—Cindy (Jingfei) Tai, Vice President of Amazon Worldwide & Executive President, Amazon Global Selling-Asia, Amazon

—Wang Ai’ying, VP/GM for APAC Electrical Component Division, Eaton Corp

—Wang Lin, Director, Takeda Development Center (TDC) Asia

—Wei Li, Director, Beijing GeoEnviron Engineering and Technology

—Xi Ye, Regional Director, Global Industrial Refrigeration Products and Solutions Asia Pacific, Johnson Controls

—Xiao Ruiping, Founder and Chairperson, Hope Medicine

—Xiong Rong, Founder and CEO, IPLUS MOBOT

—Xu Chunling, Vice President, Zhejiang Conba Pharmaceutical

—Yan Yan, Director, Jiangsu Cnano Technology

—Yang Ling, Senior Vice President, Wonders Information

—Yang Siping, Senior Manager of Intelligent Multimedia Division, MediaTek

—Ye Fei, Vice President, Shugen Internet

—Yi Ren, Privacy Computing Scientist, Transwarp Technology (Shanghai)

—Yin Yonglei, Deputy General Manager and Head of Production, Imeik Technology Development

—Yu Lihua, Greater China General Manager, Cytiva

—Zeng Fanyi, Director, Shanghai Institute of Medical Genetics (SIMG)

—Zhang Guihong, Independent Director, Jinyu Bio-Technology

—Zhao Feng, Greater China Chief IT Officer, L’Oreal

—Zhao Renbin, Executive Director & Vice President of Registration and Clinical Development, InnoCare Pharma

—Zhou Yun, General Manager of Total Risk Management, Ant Group

—Zhu Zhengyu, Vice President, Shenzhen Kangtai Biological Products

—Zou Jianjun, Deputy General Manager, Jiangsu Hengrui Medicine .

* in alphabetical order of surnames; compiled by June Li and Steven Shao

See Related Post:

Forbes China: Women In Tech (2020)

What do you think?

The Innovation Most Desperately Needed By The Space Force

NFTs Are Fueling Authenticity For Digital Assets And Have The Potential To Create New Use Cases